LEF1 and COVID-19: In line with these data, it is possible to speculate that LEF1-AS1 can serve as COVID-19 severity and outcome predictor at two levels, one in the PBMCs and the other in the plasma, where it decreases or increases, respectively, at disease condition worsening.